Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can fibrinolytic system components explain cognitive impairment in multiple sclerosis?

Journal of the neurological sciences - 15 Nov 2017

Pérez-Martín María Yaiza, González-Platas Montserrat, Jiménez-Sosa Alejandro, Plata-Bello Julio, Carrillo-Padilla Francisco Javier, Franco-Maside Andrés, Eguia-Del Río Pablo

Abstract excerpt

BACKGROUND: The fibrinolytic system is capable of modulating inflammatory and degenerative events within the central nervous system. Specifically, the plasminogen activator inhibitor-1 (PAI-1) has been associated with different pathological conditions in multiple sclerosis (MS) and its role in cognitive functioning is also known. OBJECTIVES AND METHODS: To study the association between plasma levels and the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers
Share to Cognitive Dysfunction

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Variation

Share to Multiple Sclerosis

Share to Neuropsychological Tests

Share to Plasminogen Activator Inhibitor 1

Source

Identifiers

PMID: 29111023
DOI: 10.1016/j.jns.2017.09.034

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can fibrinolytic system components explain cognitive impairment in multiple sclerosis?PMID 29111023Read ↗

PAI and TPA gene polymorphisms in multiple sclerosis.Semantic proximity Read ↗

Identifying the Distinct Cognitive Phenotypes in Multiple Sclerosis.Semantic proximity Read ↗

Cognitive phenotypes in multiple sclerosis.Semantic proximity Read ↗

The association of apolipoprotein E (ApoE) genotype and cognitive outcomes in multiple sclerosis; a systematic review and meta-analysis.Semantic proximity Read ↗

Age- and Sex-Different Associations between Cognitive Performance and Inflammatory Biomarkers in Community Dwelling Older Adults: towards Precision Preventive Strategies.Semantic proximity Read ↗

The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.Semantic proximity Read ↗

An APOA1 promoter polymorphism is associated with cognitive performance in patients with multiple sclerosis.Semantic proximity Read ↗

Association between the -844 G>A, HindIII C>G, and 4G/5G PAI-1 Polymorphisms and Susceptibility to Multiple Sclerosis in Western Mexican Population.Semantic proximity Read ↗

[Relationship between fibrinolytic system and neurological diseases].Semantic proximity Read ↗

APOE and risk of cognitive impairment in multiple sclerosis.Semantic proximity Read ↗

Gender-related effect of clinical and genetic variables on the cognitive impairment in multiple sclerosis.Semantic proximity Read ↗

Predominant cognitive phenotypes in multiple sclerosis: Insights from patient-centered outcomes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.